ALX Oncology Holdings's market cap is currently $59.07M. The company's EPS TTM is $-2.98; its P/E ratio is ―; ALX Oncology Holdings is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.67. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 1.18M	$ 4.80M
Gross Profit	$ -836.00K	$ -1.47M	$ -736.00K	$ 107.00K	$ 436.00K
Operating Income	$ -170.28M	$ -127.44M	$ -83.56M	$ -43.66M	$ -19.18M
EBITDA	$ -158.40M	$ -121.95M	$ -83.47M	$ -43.46M	$ -18.76M
Net Income	$ -160.81M	$ -123.48M	$ -83.46M	$ -45.74M	$ -19.24M
Balance Sheet
Cash & Short-Term Investments	$ 182.74M	$ 282.91M	$ 363.67M	$ 434.22M	$ 9.02M
Total Assets	$ 242.55M	$ 306.49M	$ 380.18M	$ 436.05M	$ 10.68M
Total Debt	$ 17.20M	$ 10.43M	$ 742.00K	$ 0.00	$ 5.42M
Net Debt	$ -5.21M	$ -272.48M	$ -362.93M	$ -434.22M	$ -3.60M
Total Liabilities	$ 52.84M	$ 43.02M	$ 17.13M	$ 436.05M	$ 10.95M
Stockholders' Equity	$ 189.71M	$ -325.47M	$ -201.99M	$ -118.52M	$ -276.00K
Cash Flow
Free Cash Flow	$ -131.64M	$ -90.65M	$ -73.02M	$ -38.32M	$ -14.60M
Operating Cash Flow	$ -130.36M	$ -89.22M	$ -68.10M	$ -38.29M	$ -14.25M
Investing Cash Flow	$ 44.66M	$ -235.42M	$ -4.92M	$ 610.00K	$ -353.00K
Financing Cash Flow	$ 59.29M	$ 9.86M	$ 2.47M	$ 462.88M	$ 15.36M

Currency in USD

ALX Oncology Holdings Earnings and Revenue History

Income Statement >

ALX Oncology Holdings Debt to Assets

Balance Sheet >

ALX Oncology Holdings Cash Flow

Cash Flow >

ALX Oncology Holdings Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing